CAS: 1415560-69-8 - 2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1)
Formula:C21H22Cl2FN5O·ClH
InChI:InChI=1S/C21H22Cl2FN5O.ClH/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15;/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27);1H/t12-;/m1./s1
InChI key:InChIKey=BTDNHKQCPIBABF-UTONKHPSSA-N
SMILES:Cl.FC1=CC=C(Cl)C(=C1Cl)C(OC=2C=C(C=NC2N)C=3C=NN(C3)C4CCNCC4)C
- Synonyms:
- 2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1)
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1) REF: IN-DA001GKMCAS: 1415560-69-8 | 98% | 110.00 €~623.00 € | Mon 16 Dec 24 | |
Crizotinib hydrochloride REF: TM-T8399CAS: 1415560-69-8 | 99.67% | 36.00 €~222.00 € | Mon 23 Dec 24 | |
Crizotinib hydrochloride REF: 3D-QGC56069CAS: 1415560-69-8 | Min. 95% | - - - | Discontinued product |
2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1)
Ref: IN-DA001GKM
5mg | 110.00 € | ||
25mg | 176.00 € | ||
50mg | 193.00 € |
Crizotinib hydrochloride
Ref: TM-T8399
5mg | 36.00 € | ||
10mg | 52.00 € | ||
25mg | 81.00 € | ||
50mg | 98.00 € | ||
100mg | 135.00 € | ||
200mg | 168.00 € | ||
500mg | 222.00 € | ||
1mL*10mM (DMSO) | 59.00 € |
Crizotinib hydrochloride
Ref: 3D-QGC56069
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |